000 | 01142 a2200325 4500 | ||
---|---|---|---|
005 | 20250516224418.0 | ||
264 | 0 | _c20140728 | |
008 | 201407s 0 0 eng d | ||
022 | _a2213-0489 | ||
024 | 7 |
_a10.1016/j.lrr.2014.06.003 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGoldberg, Stuart L | |
245 | 0 | 0 |
_aAn exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes. _h[electronic resource] |
260 |
_bLeukemia research reports _c2014 |
||
300 |
_a58-61 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
700 | 1 | _aFenaux, Pierre | |
700 | 1 | _aCraig, Michael D | |
700 | 1 | _aGyan, Emmanuel | |
700 | 1 | _aLister, John | |
700 | 1 | _aKassis, Jeannine | |
700 | 1 | _aPigneux, Arnaud | |
700 | 1 | _aSchiller, Gary J | |
700 | 1 | _aJung, JungAh | |
700 | 1 | _aJane Leonard, E | |
700 | 1 | _aFingert, Howard | |
700 | 1 | _aWestervelt, Peter | |
773 | 0 |
_tLeukemia research reports _gvol. 3 _gno. 2 _gp. 58-61 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.lrr.2014.06.003 _zAvailable from publisher's website |
999 |
_c24047493 _d24047493 |